Verma, Sachin
Crawford, David
Khateb, Ali
Feng, Yongmei
Sergienko, Eduard
Pathria, Gaurav
Ma, Chen-Ting
Olson, Steven H.
Scott, David
Murad, Rabi
Ruppin, Eytan
Jackson, Michael
Ronai, Ze’ev A. https://orcid.org/0000-0002-3859-0400
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R35CA197465, P30CA030199)
Article History
Received: 24 September 2021
Accepted: 26 July 2022
First Online: 1 September 2022
Competing interests
: Z.A.R. and E.R. (fully divested) are founders and scientific advisors for Pangea Therapeutics. All other authors declare no conflicts of interest.